https://staybletherapeutics.com/cision-feed/ 2025-08-20T05:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-intends-to-be-listed-on-nasdaq-first-north-growth-market-and-carries-out-a-new-issue-in-connection-to-the-listing/ 2020-01-30T19:44:55+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-publishes-prospectus-relating-to-the-issuance-of-units-in-connection-with-the-intended-listing-on-nasdaq-first-north-growth-market/ 2020-01-31T14:58:24+00:00 https://staybletherapeutics.com/cision-feed/the-subscription-period-for-staybles-new-issue-in-connection-to-the-intended-listing-on-nasdaq-first-north-growth-market-begins-today-and-the-company-invites-to-investment-events/ 2020-02-04T09:21:15+00:00 https://staybletherapeutics.com/cision-feed/tomorrow-is-the-last-day-of-subscription-for-staybles-new-issue-in-connection-to-the-intended-listing-on-nasdaq-first-north-growth-market/ 2020-02-17T14:42:55+00:00 https://staybletherapeutics.com/cision-feed/staybles-new-issue-was-subscribed-to-436/ 2020-02-21T13:27:01+00:00 https://staybletherapeutics.com/cision-feed/stayble-has-been-approved-for-listing-on-nasdaq-first-north-growth-market-with-first-day-of-trading-march-9-2020/ 2020-03-04T14:10:04+00:00 https://staybletherapeutics.com/cision-feed/stayble-appoints-mangold-as-liquidity-provider/ 2020-03-06T08:26:50+00:00 https://staybletherapeutics.com/cision-feed/the-trade-in-staybles-shares-and-warrants-on-nasdaq-first-north-growth-markets-commences-today/ 2020-03-09T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-has-submitted-applications-to-regulatory-authorities-in-the-netherlands-for-start-of-the-phase-2b-clinical-trial/ 2020-03-09T09:15:46+00:00 https://staybletherapeutics.com/cision-feed/stayble-has-submitted-applications-to-regulatory-authorities-in-spain-for-start-of-the-phase-2b-clinical-trial/ 2020-03-17T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-receives-approval-from-regulatory-authorities-to-start-clinical-phase-2b-study-in-the-netherlands/ 2020-03-17T17:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-has-together-with-apl-completed-manufacturing-of-the-investigational-drug-for-the-upcoming-clinical-phase-2b-study/ 2020-04-14T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-publishes-the-annual-report-for-2019/ 2020-04-21T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-receives-approval-from-regulatory-authorities-to-start-clinical-phase-2b-study-in-spain/ 2020-05-01T11:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-receives-approval-from-regulatory-authorities-to-start-clinical-phase-2b-study-with-sta363-in-russia/ 2020-05-20T04:30:00+00:00 https://staybletherapeutics.com/cision-feed/report-from-the-annual-general-meeting-of-stayble-therapeutics-on-june-8-2020/ 2020-06-08T11:45:00+00:00 https://staybletherapeutics.com/cision-feed/staybles-clinical-phase-2b-study-has-started/ 2020-06-16T12:00:00+00:00 https://staybletherapeutics.com/cision-feed/staybles-clinical-phase-2b-study-has-now-also-started-in-the-netherlands/ 2020-07-02T06:30:00+00:00 https://staybletherapeutics.com/cision-feed/staybles-clinical-phase-2b-study-has-now-also-started-in-the-netherlands-2/ 2020-07-02T06:30:00+00:00 https://staybletherapeutics.com/cision-feed/first-patient-treated-in-staybles-clinical-phase-2b-study/ 2020-07-31T10:00:00+00:00 https://staybletherapeutics.com/cision-feed/staybles-pre-clinical-data-and-the-clinical-phase-1b-study-on-sta363-is-published-in-the-journal-spine/ 2020-10-01T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-initiates-clinical-phase-2b-study-in-spain/ 2020-10-06T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-presents-at-eurospine-annual-meeting-2020/ 2020-10-07T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/the-exercise-price-for-the-warrants-of-series-to1-in-stayble-therapeutics-ab-has-been-set-to-sek-1230/ 2020-11-16T07:30:00+00:00 https://staybletherapeutics.com/cision-feed/the-subscription-period-for-the-warrants-of-series-to1-in-stayble-therapeutics-ab-begins-today-october-17-2020/ 2020-11-17T07:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-announces-the-outcome-of-the-exercise-of-warrants-of-series-to1/ 2020-12-04T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-resolves-on-a-rights-issue-in-order-to-ensure-the-completion-of-the-ongoing-phase-2b-study/ 2020-12-18T15:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-strengthens-its-scientific-advisory-board-with-us-focused-key-opinion-leaders/ 2021-01-21T11:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-publishes-prospectus-in-connection-with-the-forthcoming-rights-issue/ 2021-01-27T14:55:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-publishes-prospectus-in-connection-with-the-forthcoming-rights-issue-2/ 2021-01-27T14:55:00+00:00 https://staybletherapeutics.com/cision-feed/the-subscription-period-in-stayble-therapeutics-rights-issue-begins-today/ 2021-02-03T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/information-about-the-trading-in-subscription-rights-and-bta/ 2021-02-03T10:40:02+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-rights-issue-oversubscribed/ 2021-02-22T08:30:00+00:00 https://staybletherapeutics.com/cision-feed/last-day-of-trading-in-bta/ 2021-03-04T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-appoints-professor-hans-jorg-meisel-as-a-member-of-the-scientific-advisory-board/ 2021-03-10T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-provides-update-on-the-ongoing-phase-2b-study-due-to-the-covid-19-pandemic/ 2021-04-21T09:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-strengthens-its-team-by-recruiting-vp-cmc-and-regulatory-affairs/ 2021-04-28T09:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-publishes-the-annual-report-for-2020/ 2021-05-03T09:00:00+00:00 https://staybletherapeutics.com/cision-feed/kallelse-till-arsstamma-i-stayble-therapeutics-ab/ 2021-05-03T10:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-offentliggor-kvartalsrapport-for-q1-2021/ 2021-05-17T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/se-kommunike-fran-arsstamma-i-stayble-therapeutics-den-2-juni-2021/ 2021-06-02T09:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-offentliggor-kvartalsrapport-for-q2-2021/ 2021-08-16T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-interim-data-from-the-ongoing-phase-2b-study/ 2021-11-04T19:30:00+00:00 https://staybletherapeutics.com/cision-feed/se-stayble-therapeutics-ab-offentliggor-kvartalsrapport-for-q3-2021/ 2021-11-18T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presented-at-swedish-shareholders-associations-event-stora-aktiedagen-stockholm-2021/ 2021-12-01T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/analysguiden-has-completed-an-analysis-of-stayble-therapeutics-and-initiates-equity-research-coverage/ 2022-02-01T08:17:36+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publication-of-year-end-report-2021/ 2022-02-22T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-comments-the-ongoing-study-in-russia/ 2022-03-14T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presented-at-swedish-shareholders-associations-event-aktiedagen-stockholm-2022/ 2022-03-15T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-changes-certified-adviser-to-svensk-kapitalmarknadsgranskning-ab/ 2022-03-30T12:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-changes-certified-adviser-to-svensk-kapitalmarknadsgranskning-ab-2/ 2022-03-30T12:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-has-recruited-75-of-the-patients-in-the-ongoing-phase-iib-trial/ 2022-04-25T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/publication-of-stayble-therapeutics-2021-annual-report/ 2022-05-02T07:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-appoints-lago-kapital-ab-as-liquidity-provider/ 2022-05-06T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-interim-report-for-the-first-quarter/ 2022-05-17T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/se-kommunike-fran-arsstamma-i-stayble-therapeutics/ 2022-06-01T11:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-half-year-report-for-2022/ 2022-08-16T05:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-reaches-important-milestone-phase-iib-study-fully-recruited/ 2022-08-31T04:25:00+00:00 https://staybletherapeutics.com/cision-feed/ceo-buys-shares-in-stayble-therapeutics/ 2022-09-01T08:30:00+00:00 https://staybletherapeutics.com/cision-feed/kalqyl-publishes-analysis-of-stayble-therapeutics/ 2022-09-19T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/continued-good-compliance-in-stayble-therapeutics-phase-iib-study/ 2022-10-17T09:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-at-stora-aktiedagen-in-gothenburg/ 2022-11-07T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-interim-report-for-the-third-quarter-2022/ 2022-11-15T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-at-prohearings-capital-market-day-on-december-1-2022/ 2022-11-30T06:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-the-ongoing-phase-2b-study-at-the-european-congress-on-clinical-trials-in-pain/ 2022-12-06T13:01:28+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-year-end-report-for-2022/ 2023-02-21T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-starts-development-of-a-new-clinical-indication-and-decides-on-a-rights-issue-of-approximately-msek-35-2/ 2023-02-22T19:14:00+00:00 https://staybletherapeutics.com/cision-feed/se-kallelse-till-extra-bolagsstamma-i-stayble-therapeutics-ab/ 2023-02-22T19:20:03+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-receives-approval-to-start-phase-ib-clinical-trial-with-sta363-for-the-treatment-of-herniated-discs/ 2023-02-28T22:08:39+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-at-the-life-science-day-in-gothenburg-march-8-2023/ 2023-03-07T12:00:00+00:00 https://staybletherapeutics.com/cision-feed/se-kommunike-fran-extra-bolagsstamma-i-stayble-therapeutics-ab/ 2023-03-16T13:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-publishes-prospectus-relating-to-the-rights-issue/ 2023-03-17T11:40:00+00:00 https://staybletherapeutics.com/cision-feed/staybie-therapeutics-ab-receives-additional-pre-subscription-and-underwriting-commitments-for-the-upcoming-rights-issue/ 2023-03-23T19:30:00+00:00 https://staybletherapeutics.com/cision-feed/today-the-subscription-period-of-staybie-therapeutics-abs-rights-issue-starts/ 2023-03-24T07:30:00+00:00 https://staybletherapeutics.com/cision-feed/staybie-therapeutics-ab-receives-additional-underwriting-commitments-for-the-ongoing-rights-issue/ 2023-03-28T13:40:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-publishes-supplementary-prospectus-regarding-the-rights-issue/ 2023-03-29T09:25:01+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-abs-ceo-presents-the-company-and-the-rights-issue/ 2023-04-03T11:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-positive-interim-data-from-ongoing-phase-2b-study/ 2023-04-05T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-announces-outcome-from-concluded-rights-issue/ 2023-04-13T16:07:27+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-appoints-jarkko-kalliomaki-as-chief-medical-officer/ 2023-04-19T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-implements-directed-offset-issue-to-underwriters-in-connection-with-the-concluded-rights-issue/ 2023-04-25T15:04:57+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-announces-dr-daisuke-sakai-as-new-scientific-advisor/ 2023-04-26T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-ab-announces-last-day-of-trading-with-bta/ 2023-04-28T06:36:36+00:00 https://staybletherapeutics.com/cision-feed/se-kallelse-till-arsstamma-i-stayble-therapeutics-ab/ 2023-05-02T12:43:24+00:00 https://staybletherapeutics.com/cision-feed/se-stayble-therapeutics-publicerar-arsredovisningen-for-2022/ 2023-05-09T12:01:18+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-interim-report-for-the-first-quarter-2023/ 2023-05-23T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/se-kommunike-fran-arsstamman-i-stayble-therapeutics/ 2023-06-01T11:12:02+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-visited-the-bio-international-convention-in-boston/ 2023-06-12T10:30:00+00:00 https://staybletherapeutics.com/cision-feed/90-have-completed-12-month-follow-up-in-stayble-therapeutics-ongoing-phase-iib-study-2/ 2023-07-12T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/90-have-completed-12-month-follow-up-in-stayble-therapeutics-ongoing-phase-iib-study/ 2023-07-12T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-half-year-report-for-2023/ 2023-08-22T08:29:48+00:00 https://staybletherapeutics.com/cision-feed/first-patient-enrolled-in-stayble-therapeutics-phase-1b-clinical-study-in-herniated-discs/ 2023-08-28T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-terminates-agreement-regarding-liquidity-provider/ 2023-09-06T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-announces-final-patients-last-visit-in-the-phase-2b-clinical-study/ 2023-09-06T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-at-financial-stockholms-investor-meeting-on-september-25-2023/ 2023-09-21T08:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-engages-ferghana-partners-to-support-partnering-activities/ 2023-10-24T08:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-reports-top-line-data-from-the-companys-phase-iib-study/ 2023-11-09T05:50:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-interim-report-for-the-third-quarter-of-2023/ 2023-11-14T06:35:00+00:00 https://staybletherapeutics.com/cision-feed/correction-stayble-therapeutics-publishes-interim-report-for-the-third-quarter-of-2023/ 2023-11-14T07:15:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-phase-iib-data-support-effectiveness-in-treating-herniated-discs/ 2023-12-12T12:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-the-final-data-from-the-phase-iib-study/ 2024-01-05T10:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-secures-all-key-data-from-ongoing-phase-iib-study-with-sta363/ 2024-01-10T12:09:23+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-year-end-report-for-2023/ 2024-02-20T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/all-patients-included-in-stayble-therapeutics-phase-ib-study-in-disc-hernia-with-sta363/ 2024-03-05T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/abstract-on-sta363s-clinical-effect-on-disc-volume-has-been-accepted-for-presentation-at-an-important-congress/ 2024-04-03T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/sv-kallelse-till-arsstamma-i-stayble-therapeutics-ab/ 2024-04-15T05:30:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-publicerar-arsredovisningen-for-2023/ 2024-04-17T10:38:36+00:00 https://staybletherapeutics.com/cision-feed/sv-kommunike-fran-arsstamman-i-stayble-therapeutics/ 2024-05-15T09:49:39+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-interim-report-for-the-first-quarter-of-2024/ 2024-05-21T04:30:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-ab-publ-genomfor-en-riktad-emission-av-units-om-totalt-cirka-tre-miljoner-kronor-infor-kommande-resultat-fran-fas-1b-studien/ 2024-06-11T17:00:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-ab-publ-offentliggor-utfall-i-riktad-emission-av-units/ 2024-06-14T08:04:45+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-presents-positive-interim-data-from-the-ongoing-phase-ib-study-with-sta363/ 2024-06-25T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-appoints-new-cfo/ 2024-07-23T09:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-half-year-report-for-2024/ 2024-08-20T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-receives-its-first-approved-patent-for-the-treatment-of-herniated-discs/ 2024-09-05T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/the-last-patient-visit-was-completed-in-stayble-therapeutics-herniated-disc-study/ 2024-09-12T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/the-european-patent-office-announces-its-intention-to-grant-staybles-patent-for-the-treatment-of-disc-herniation/ 2024-10-30T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-sta363-receives-positive-phase-1b-results/ 2024-11-13T17:01:04+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-interim-report-for-the-third-quarter-of-2024/ 2024-11-29T06:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-reports-additional-data-strengthening-the-sta363-treatment-for-pain-caused-by-disc-herniation/ 2024-12-11T10:30:00+00:00 https://staybletherapeutics.com/cision-feed/staybles-ceo-andreas-gerward-presented-in-swedish-at-financial-stockholm-on-december-11-2024/ 2024-12-13T08:30:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-accelerates-partnering-process-with-the-support-of-advisors/ 2024-12-18T06:30:00+00:00 https://staybletherapeutics.com/cision-feed/interview-with-jane-buus-laursen-an-experienced-pharma-dealmaker-and-board-member-of-stayble/ 2025-01-02T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/interview-with-us-payer-expert-on-the-us-market-and-sta363s-potential/ 2025-01-14T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/abstract-on-the-effect-of-sta363-on-disc-volume-from-the-phase-1b-study-has-been-accepted-for-oral-presentation-at-a-major-international-congress/ 2025-01-22T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-ab-publ-offentliggor-utfallet-av-utnyttjande-av-teckningsoptioner-av-serie-to2/ 2025-01-31T14:16:24+00:00 https://staybletherapeutics.com/cision-feed/stayble-provides-update-on-partnership-activities/ 2025-02-18T06:00:00+00:00 https://staybletherapeutics.com/cision-feed/stayble-therapeutics-publishes-year-end-report-for-2024/ 2025-02-25T06:35:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-ab-publ-genomfor-en-riktad-emission-av-units-om-totalt-cirka-455-miljoner-kronor/ 2025-05-02T16:45:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-senarelagger-publicering-av-arsredovisning-2024-till-den-14-maj/ 2025-05-06T09:33:05+00:00 https://staybletherapeutics.com/cision-feed/sv-kallelse-till-arsstamma-i-stayble-therapeutics-ab-publ/ 2025-05-06T09:38:16+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-ab-publ-offentliggor-utfall-i-riktad-emission-av-units-2/ 2025-05-08T04:00:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-publicerar-arsredovisningen-for-2024/ 2025-05-14T08:30:00+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-offentliggor-kvartalsrapport-for-forsta-kvartalet-2025/ 2025-05-21T04:30:00+00:00 https://staybletherapeutics.com/cision-feed/sv-kommunike-fran-arsstamma-i-stayble-therapeutics/ 2025-06-05T11:48:35+00:00 https://staybletherapeutics.com/cision-feed/sv-stayble-therapeutics-offentliggor-halvarsrapport-for-2025/ 2025-08-20T05:00:00+00:00